What Is Immunotherapy for Metastatic Bladder Cancer?
' + "
";
evCat = 'adx-impl';
evLabel = '/21865806531/yl-xk/336*280-01-wap-xk-yl';
} else {
html = "
" + '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/728*90-01-pc-xk-yl", [728, 90], "div-gpt-ad-1576640512222-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640512222-0")});
' + "
";
evCat = 'adx-impl';
evLabel = '/21865806531/yl-xk/728*90-01-pc-xk-yl';
}
var html2 = replaceAll2(html, "script2", "script");
fillHtml += randomAdxSlotId(html2);
_pf_event(evCat, PAGE_CAT, evLabel);
_pf_log("ga adsense single");
}
document.write(fillHtml);
}
showAd();
})();
Q: I have metastatic bladder cancer and my doctor recommended me to take immunotherapy. Whatâs immunotherapy?
A: Immunotherapy is a type of treatment for metastatic bladder cancer. In this method, your bodyâs own immune system attacks the cancer cells. People with baldder cancer taking the treatment now have a few immunotherapy drugs for their disease.
Atezolizumab (Tecentriq) is the medicine for the most common type of bladder cancer, urothelial carcinoma.
Nivolumab (Opdivo) is the medicine for people with advanced urothelial carcinoma whose cancer has spread after theyâve tried chemotherapy.
Researchers are now testing other drugs which are potentially effective for bladder cancer. The combination of immunotherapies is a new direction in experiment.
Related FAQs:
New Cure for Cancer Discovered, Save Lots of Lives
What Is the Treatment for Bladder Cancer?
How Could the Diabetic Complication Deprive My Dad of His Life Only Within 6 Hours?
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
";
}
function showAd(){
var s = getQueryStringByName('s');
var isSearchPage = (s != '');
var isMobile = /iPhone|iPad|iPod|Android/i.test(navigator.userAgent);
var html = '';
var html2 = '';
if (isSearchPage) {
if (isMobile) {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-01-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640284306-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640284306-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-01-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-02-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640310637-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640310637-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-02-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-03-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640337768-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640337768-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-03-wap-n-xk-yl');
} else {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-pc-n-xk-yl", [300, 600], "div-gpt-ad-1576640117816-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640117816-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-pc-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-02-pc-n-xk-yl", [300, 600], "div-gpt-ad-1576640172416-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640172416-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-02-pc-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
}
} else {
if (isMobile) {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-04-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640363074-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640363074-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-04-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-05-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640388002-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640388002-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-05-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-06-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640412938-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640412938-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-06-wap-n-xk-yl');
} else {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x250-01-healthtopquestions-xk-yl", [300, 250], "div-gpt-ad-1576639270555-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639270555-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x250-01-healthtopquestions-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
}
}
var html2 = replaceAll2(html, 'script2', 'script');
document.write(html2);
}
showAd();
})();